BD Intelliport Medication Management System Sensor The system is indicated for use by healthca...
FDA Device Recall #Z-1076-2016 — Class II — December 9, 2015
Recall Summary
| Recall Number | Z-1076-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | December 9, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Becton Dickinson & Company |
| Location | Franklin Lakes, NJ |
| Product Type | Devices |
| Quantity | 250 units |
Product Description
BD Intelliport Medication Management System Sensor The system is indicated for use by healthcare professionals in a hospital or medical center setting with patients who are receiving manually administered bolus intravenous injections as part of their care to facilitate documentation of the medications.
Reason for Recall
The sterility of the product cannot be assured. This may result in increased risk of infection.
Distribution Pattern
US Distribution to:California and Utah.
Lot / Code Information
Catalog (Ref) # 516700 Lot numbers 5222723, 5251583 and 5253723.
Other Recalls from Becton Dickinson & Company
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2257-2026 | Class I | BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3... | Apr 27, 2026 |
| Z-2249-2026 | Class I | BD¿Spinal Tray with BD¿Quincke Needle 25 G x 3.... | Apr 27, 2026 |
| Z-2251-2026 | Class I | BD¿Spinal Tray with BD¿Whitacre Needle 22 G x 3... | Apr 27, 2026 |
| Z-2255-2026 | Class I | BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3... | Apr 27, 2026 |
| Z-2256-2026 | Class I | BD¿Spinal Tray with BD¿Whitacre Needle 25 G x 3... | Apr 27, 2026 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.